Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Resetting epigenetic code could aid lupus patients

08.11.2005


Researchers at Wake Forest University School of Medicine and the University of Virginia hope to reset part of the "epigenetic code" in lupus patients and thus improve treatment.



The epigenetic research focuses on histones, the tiny spools in the nuclei of cells around which DNA winds and compacts when it is not in the process of copying in cell division. Epigenetic changes in the histones are those that can alter gene expression – and associated proteins – without altering the underlying DNA sequence, said Nilamadhab Mishra, M.D., a rheumatologist at Wake Forest University Baptist Medical Center.

"The histone code is one of the master regulators in gene expression," he said.


In the Journal of Proteome Research of the American Chemical Society, Mishra and colleagues said their study was the first to establish the association between aberrant histone codes and the mechanisms underlying lupus (systemic lupus erythematosus), which is an autoimmune disorder. The online version appeared this weekend. The researchers identified three new histone modifications in mice with a lupus-like condition that were not found previously. The team found that by using compounds called HDAC (histone deacetylase) inhibitors, they could reverse the modifications and reset the histone code.

In the mice with lupus, Mishra has been testing several HDAC inhibitors, one called trichostatin A (TSA) and another called SAHA, both of which successfully treat lupus symptoms. The new research may help explain the reasons why the treatments work.

Without treatment, he said, these mice have an accelerated autoimmune disorder that produces a host of symptoms from arthritis and enlarged spleens to failing kidneys. Half are dead in 24 weeks, primarily of kidney failure. Control mice of the same type, but without lupus, live much longer; the females dying at 73 weeks and the males at 93 weeks.

In essence, Mishra said, the HDAC inhibitors reset the histone modifications, reducing or eliminating the lupus condition. "If we modify the histone with a drug, we can also cure the lupus."

The work is part of the effort to unravel a number of the mysteries of lupus: Why does it occur in one identical twin and usually not the other, though they have exactly the same DNA? Why does lupus strike predominantly women? Why does it abruptly strike some while they are still young, others in middle age and others not until old age?

Mishra said the proteins expressed through the histones vary between healthy individuals and lupus patients. There also is variation among lupus patients. These differences may explain why some lupus patients develop kidney disease and others do not, or other symptoms like arthritis or skin disorders.

Prior to this research, the prevailing theory is that the variations were due to differences in genetic background and the influences of the environment. Mishra’s mouse models are all genetically identical, yet variations exist. "They are the same, but different," he said. Histone changes could explain these differences. Mishra said that in addition to the use of HDAC inhibitors, combination treatment for lupus might also include a methylase inhibitor. But those don’t exist yet.

Lupus is a chronic inflammatory autoimmune disorder that affects the skin, kidneys, joints, lungs, blood and central nervous system. Systemic lupus affects more than 1 million Americans, mostly women.

Mishra’s coauthors are Benjamin A. Garcia, Ph.D., Scott A. Busby, Ph.D., Jeffrey Shabanowitz, Ph.D., and Donald F. Hunt, Ph.D., of the University of Virginia, Charlottesville.

Robert Conn | EurekAlert!
Further information:
http://www.wfubmc.edu

More articles from Life Sciences:

nachricht Fingerprint' technique spots frog populations at risk from pollution
27.03.2017 | Lancaster University

nachricht Parallel computation provides deeper insight into brain function
27.03.2017 | Okinawa Institute of Science and Technology (OIST) Graduate University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Northern oceans pumped CO2 into the atmosphere

27.03.2017 | Earth Sciences

Fingerprint' technique spots frog populations at risk from pollution

27.03.2017 | Life Sciences

Big data approach to predict protein structure

27.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>